Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KHK4083 Phase 2b in Atopic Dermatitis
NCT03703102Phase 2Completed
- Sponsor
- Kyowa Kirin
- Start
- Oct 2018
- Primary completion
- Feb 2020
- Modality
- Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 2 trial of rocatinlimab in atopic dermatitis (AD), sponsored by Kyowa Kirin. Started Oct 2018; status: completed.
02
Drugs
rocatinlimab
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03703102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03703102.